Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Hypoglycemia – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest pipeline guide…
DUBLIN–(BUSINESS WIRE)–The “Alzheimer’s Disease: Pipeline Review, Developer Landscape and Competitive Insights” report has been added to ResearchAndMarkets.com’s offering. Alzheimer’s disease…
DUBLIN–(BUSINESS WIRE)–The “Post-Operative Pain – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. This latest Pharmaceutical…
Chinese registrational clinical trial for derazantinib to begin in 2H 2019 BURLINGTON, Mass.–(BUSINESS WIRE)–lt;a href=”https://twitter.com/search?q=%24ARQL&src=ctag” target=”_blank”gt;$ARQLlt;/agt; lt;a href=”https://twitter.com/hashtag/arql?src=hash” target=”_blank”gt;#arqllt;/agt;–ArQule, Inc.’s…
Revenuegenerated by Hepatitis A vaccine increased by $12.0 million comparedto same period in 2017, which was offset by $13.6 million decrease in
Based on the source, the market was dominated by the bacteria-basedprobiotic supplements segment, with a 91% share in 2017. Most probioticsupplements include bacterial strains, of which, Lactobacillus sp andBifidobacterium sp are used widely for the maintenance of healthymicrobiota.
DUBLIN–(BUSINESS WIRE)–The “Drug Addiction – Pipeline Review, H1 2019” report has been added to ResearchAndMarkets.com’s offering. Drug Addiction – Pipeline…
DUBLIN–(BUSINESS WIRE)–The “Idiopathic Pulmonary Fibrosis: Competitive Landscape to 2026” report has been added to ResearchAndMarkets.com’s offering. “Idiopathic Pulmonary Fibrosis: Competitive…
Inclisiran’s unique profile, vast global market opportunity and long-dated exclusivity set the stage for potentially significant shareholder value creation Independent…
Aptorum Group Limited has established new subsidiary group, Smart Pharma